Prime Medicine, Inc. (NYSE:PRME) Receives Consensus Recommendation of "Moderate Buy" from Brokerages themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Clearmind Medicine Files U.S. Patent Application for Psychedelic-Based Treatment for Eating Disorders tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
Prime Medicine, Inc. (NYSE:PRME – Get Free Report)’s share price gapped down before the market opened on Wednesday . The stock had previously closed at $6.18, but opened at $5.82. Prime Medicine shares last traded at $5.84, with a volume of 56,931 shares trading hands. Analyst Ratings Changes A number of analysts recently weighed in […]
Clearmind Medicine CEO Issues Letter to Shareholders tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
Prime Medicine, Inc. (NYSE:PRME – Get Free Report)’s stock price hit a new 52-week low on Friday . The company traded as low as $5.48 and last traded at $5.82, with a volume of 210141 shares traded. The stock had previously closed at $5.79. Wall Street Analysts Forecast Growth A number of research firms have […]